Mostrar o rexistro simple do ítem

dc.contributor.authorGonzález Rodríguez, María *
dc.contributor.authorAit Edjoudi, D.*
dc.contributor.authorCordero Barreal, Alfonso*
dc.contributor.authorFarrag, M.*
dc.contributor.authorVarela García, María*
dc.contributor.authorTorrijos-Pulpón, C.*
dc.contributor.authorRuiz Fernández, Clara*
dc.contributor.authorCapuozzo, M.*
dc.contributor.authorOttaiano, A.*
dc.contributor.authorLago Paz, Francisca *
dc.contributor.authorPino Mínguez, Jesús *
dc.contributor.authorFarrag, Y.*
dc.contributor.authorGualillo, Oreste*
dc.date.accessioned2025-09-12T11:47:26Z
dc.date.available2025-09-12T11:47:26Z
dc.date.issued2023
dc.identifier.citationGonzález-Rodríguez M, Ait Edjoudi D, Cordero-Barreal A, Farrag M, Varela-García M, Torrijos-Pulpón C, et al. Oleocanthal, an Antioxidant Phenolic Compound in Extra Virgin Olive Oil (EVOO): A Comprehensive Systematic Review of Its Potential in Inflammation and Cancer. Antioxidants. Multidisciplinary Digital Publishing Institute (MDPI); 2023;12(12).
dc.identifier.issn2076-3921
dc.identifier.otherhttps://portalcientifico.sergas.gal//documentos/65ac0cc5548ea41722b1a543
dc.identifier.urihttp://hdl.handle.net/20.500.11940/21804
dc.description.abstractBackground: The Mediterranean diet is linked to various health benefits, especially the consumption of olive oil as a key component. Multiple studies highlight its advantages, particularly due to its fatty acid composition and additional components like phenolic compounds. A significant antioxidant compound, oleocanthal, known for its antioxidant properties, has gained attention in the pharmaceutical industry for its anti-inflammatory and antiproliferative effects. It shows promise in addressing cardiovascular diseases, metabolic syndrome, and neuroprotection. This systematic review aims to evaluate the existing literature on oleocanthal, examining its role in biological processes and potential impact on conditions like inflammation and cancer. Methods: We performed several searches in PubMed (MEDLINE), Web of Science (WOS), and Cochrane based on the terms "Oleocanthal", "Cancer", and "Inflammation". The inclusion criteria were as follows: studies whose main topics were oleocanthal and cancer or inflammation. On the other hand, the exclusion criteria were studies that were not focused on oleocanthal, reviews, or editorial material. Given that these findings are explanatory rather than derived from clinical trials, we refrained from employing methods to assess potential bias. This systematic review did not receive any external funding. Results: We found 174 records from these searches, where we discarded reviews and editorial material, duplicated articles, and 1 retracted article. Finally, we had 53 reports assessed for eligibility that were included in this review. Discussion: OC exhibits promising therapeutic potential against both inflammation and cancer. We addressed its ability to target inflammatory genes and pathways, offering potential treatments for conditions like rheumatic diseases by regulating pathways such as NF-kB and MAPK. Additionally, OC's anticancer properties, particularly its notable inhibition of c-Met signaling across various cancers, highlight its efficacy, showcasing promise as a potential treatment.
dc.description.sponsorshipO.G. and F.L. are Staff Personnel (I3SNS Stable Researcher) of Xunta de Galicia (Servizo Galego de Saude (SERGAS)) through a research staff contract (ISCIII)/SERGAS). O.G. is a member of the RICORS Program, RD21/0002/0025, via ISCIII and FEDER. F.L. is a member of Centro de Investigacion Biomedica en Red de Enfermedades Cardiovasculares (CIBERCV). The work of O.G. and J.P. (PI20/00902) and F.L. (PI21/01145 and CB16/11/00226) is funded by ISCIII and FEDER. O.G. is a member of the COST action CA21110 (Building a European Network on Osteoarthritis (NETWOARK)), funded by the European Union and European Commission under the European Cooperation in science and technology program (COST). O.G. and J.P. are beneficiaries of grants funded by GEER (Sociedad Espanola de Columna vertebral) becas 2020 and 2023. O.G. is the beneficiary of a grant funded by Xunta de Galicia, Conselleria de Educacion, Universidade e Formacion Profesional and Conselleria de Economia, Emprego e Industria (GAIN) (GPC IN607B2022/02). M.G-R. is a recipient of a predoctoral contract funded by Xunta de Galicia (IN606A-2020/010). ISCIII and FEDER funded the predoctoral research scholarship granted to C.R-F. (PFIS 18/00188). A.C.B. is a recipient of a predoctoral contract funded by Secretaria de Estado de Universidades, Investigacion, Desarrollo e Innovacion, Ministerio de Universidades (FPU2018-04165). Y.F. is a 'Sara Borrell' researcher funded by ISCIII and FEDER (CD21/00042). The funders were not involved in study design, data collection and analysis, decision to publish, or manuscript preparation.
dc.languageeng
dc.rightsAttribution 4.0 International (CC BY 4.0)*
dc.rights.urihttp://creativecommons.org/licenses/by/4.0/*
dc.titleOleocanthal, an Antioxidant Phenolic Compound in Extra Virgin Olive Oil (EVOO): A Comprehensive Systematic Review of Its Potential in Inflammation and Cancer
dc.typeArtigo
dc.authorsophosGonzález-Rodríguez, M.; Ait Edjoudi, D.; Cordero-Barreal, A.; Farrag, M.; Varela-García, M.; Torrijos-Pulpón, C.; Ruiz-Fernández, C.; Capuozzo, M.; Ottaiano, A.; Lago, F.; Pino, J.; Farrag, Y.; Gualillo, O.
dc.identifier.doi10.3390/antiox12122112
dc.identifier.sophos65ac0cc5548ea41722b1a543
dc.issue.number12
dc.journal.titleAntioxidants*
dc.organizationServizo Galego de Saúde::Áreas Sanitarias (A.S.) - Instituto de Investigación Sanitaria de Santiago de Compostela (IDIS)::Endocrinoloxía e nutrición
dc.organizationServizo Galego de Saúde::Áreas Sanitarias (A.S.) - Instituto de Investigación Sanitaria de Santiago de Compostela (IDIS)
dc.organizationServizo Galego de Saúde::Áreas Sanitarias (A.S.) - Complexo Hospitalario Universitario de Ferrol::Reumatoloxía
dc.organizationServizo Galego de Saúde::Áreas Sanitarias (A.S.) - Instituto de Investigación Sanitaria de Santiago de Compostela (IDIS)::Reumatoloxía
dc.organizationServizo Galego de Saúde::Áreas Sanitarias (A.S.) - Complexo Hospitalario Universitario de Santiago::Docencia
dc.organizationServizo Galego de Saúde::Áreas Sanitarias (A.S.) - Complexo Hospitalario Universitario de Santiago::Cirurxía ortopédica e traumatoloxía
dc.organizationServizo Galego de Saúde::Áreas Sanitarias (A.S.) - Complexo Hospitalario Universitario de Santiago::Docencia
dc.relation.projectIDXunta de Galicia (Servizo Galego de Saude (SERGAS)) [RD21/0002/0025]
dc.relation.projectIDISCIII [RD21/0002/0025, PI20/00902, PI21/01145, CB16/11/00226]
dc.relation.projectIDFEDER [CA21110, FPU2018-04165]
dc.relation.projectIDCOST action - European Union [PFIS 18/00188]
dc.relation.projectIDEuropean Commission under the European Cooperation in science and technology program (COST)
dc.relation.projectIDGEER (Sociedad Espanola de Columna vertebral)
dc.relation.projectIDXunta de Galicia [CD21/00042]
dc.relation.projectIDSecretaria de Estado de Universidades, Investigacion, Desarrollo e Innovacion, Ministerio de Universidades [IN606A-2020/010]
dc.relation.publisherversionhttps://doi.org/10.3390/antiox12122112
dc.rights.accessRightsopenAccess*
dc.subject.keywordAS Santiago
dc.subject.keywordIDIS
dc.subject.keywordAS Santiago
dc.subject.keywordIDIS
dc.subject.keywordAS Ferrol
dc.subject.keywordCHUF
dc.subject.keywordAS Santiago
dc.subject.keywordIDIS
dc.subject.keywordAS Santiago
dc.subject.keywordCHUS
dc.subject.keywordAS Santiago
dc.subject.keywordCHUS
dc.subject.keywordAS Santiago
dc.subject.keywordCHUS
dc.typefidesArtículo Científico (incluye Original, Original breve, Revisión Sistemática y Meta-análisis)
dc.typesophosArtículo de Revisión
dc.volume.number12


Ficheiros no ítem

Este ítem aparece na(s) seguinte(s) colección(s)

Mostrar o rexistro simple do ítem

Attribution 4.0 International (CC BY 4.0)
A non ser que se indique outra cousa, a licenza do ítem descríbese comoAttribution 4.0 International (CC BY 4.0)